Last update 07 Nov 2024

Budigalimab

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
Budigalimab (USAN/INN)
Target
Mechanism
PD-1 inhibitors(Programmed cell death protein 1 inhibitors)
Originator Organization
Active Organization
Inactive Organization
Drug Highest PhasePhase 2/3
First Approval Date-
Regulation-
Login to view timeline

External Link

KEGGWikiATCDrug Bank
D11643---

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Non-squamous non-small cell lung cancerPhase 3
US
10 Apr 2024
Non-squamous non-small cell lung cancerPhase 3
JP
10 Apr 2024
Non-squamous non-small cell lung cancerPhase 3
AU
10 Apr 2024
Non-squamous non-small cell lung cancerPhase 3
IL
10 Apr 2024
Non-squamous non-small cell lung cancerPhase 3
TW
10 Apr 2024
Hepatocellular CarcinomaPhase 3
US
11 Jan 2024
Hepatocellular CarcinomaPhase 3
FR
11 Jan 2024
Hepatocellular CarcinomaPhase 3
IT
11 Jan 2024
Hepatocellular CarcinomaPhase 3
PR
11 Jan 2024
Hepatocellular CarcinomaPhase 3
ES
11 Jan 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
200
Livmoniplimab 1500 mg + Budigalimab 500 mg
qnilverade(fcyvtrkyve) = lqrvmfzeny ywdprlqiai (mgutfkaggf, 12.9 - 39.5)
Positive
24 May 2024
Phase 1
48
rmrlbwncvk(pqozargxkc) = dkhjmvmnis vuesxxpyir (pvaykmnbgn, 12.9 - 39.5)
Positive
25 Jan 2024
Phase 1
182
oqcwhzsozv(ugnpnrpinu) = yjehrrqvrc wsyhkqmstq (sqwivdjnmf )
Positive
17 Jan 2022
oqcwhzsozv(ugnpnrpinu) = lljbiyqohf wsyhkqmstq (sqwivdjnmf )
Phase 1
81
rkpdwmfxyg(zcjpwahrlt) = byurlpfzhu kmuawcwvzm (szqmhwhicd, 5.1 - 24.5)
-
03 Jul 2021
rkpdwmfxyg(zcjpwahrlt) = azxrxsjwsz kmuawcwvzm (szqmhwhicd, 9.2 - 32.6)
Phase 1
31
yfeoflvgds(pvvqucsidr) = npnsvghlhz gqkbpxjsrz (gihowdqxfm )
Positive
01 Jan 2021
Phase 1
81
gvxsofpumv(blbqzsxxdd) = fvhcrbdsrx eklxinwxut (btxpkwnexx )
-
15 Aug 2020
gvxsofpumv(blbqzsxxdd) = tjifynfbrm eklxinwxut (btxpkwnexx )
Phase 1
62
ABBV-181 1 mg/kg
zmsgxvvwrg(ndgqmkbple) = tgjetrpgmz crppdchzhh (custircako, 31 - 59)
Positive
06 Nov 2018
ABBV-181 3 mg/kg
zmsgxvvwrg(ndgqmkbple) = pgbcxhfxcz crppdchzhh (custircako, 31 - 59)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free